4.7 Article

New approach for the assessment of cluster diets

Journal

FOOD AND CHEMICAL TOXICOLOGY
Volume 52, Issue -, Pages 180-187

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.fct.2012.11.005

Keywords

FAO supply utilization accounts; Dietary behavior; Consumption systems; Matrix factorisation; Sparse clustering

Ask authors/readers for more resources

Dietary risk assessment is a major public health concern, positioned in the context of establishing overall food safety policy. It requires some understanding of population food choices although geographical location and social-cultural environment are variable. Several years ago, a cluster analysis based on FAO consumption data, ranging from 1990 to 1994, was at the origin of the 13, so called, GEMS/Food cluster diets. This analysis required the initial identification of 19 food markers based on geographical and cultural differences. This paper proposes a new modelling of FAO food consumption database in order to define new cluster diets based on updated consumption data from 2002 to 2007 and better adapted statistical methods. Two statistical methods were combined to extract, consumption systems that generate a substructure from the initial food consumption database and then by deriving a clustering of countries according to their consumption system profiles. The clustering resulted in 17 cluster diets composed of 2 up to 30 countries. The few discrepancies between these new clusters and former ones may be due to more recent data, and to the fact that the new approach is based on another mathematical modelling which does not require any initial identification of food markers. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Clinical

Mindfulness as a Protective Factor Against Increased Tobacco and Alcohol Use in Hospital Workers Following the First COVID-19-Related Lockdown: a Study in Southern France

Tangui Barre, Clemence Ramier, Izza Mounir, Renaud David, Loick Menvielle, Fabienne Marcellin, Patrizia Carrieri, Camelia Protopopescu, Faredj Cherikh

Summary: This study aimed to assess the protective role of dispositional mindfulness on increased tobacco and alcohol use among French hospital workers during the COVID-19 lockdown. The results showed a negative association between dispositional mindfulness and increased tobacco and alcohol use, with mindfulness partially mediating the effect of affect deterioration on tobacco use.

INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION (2023)

Article Public, Environmental & Occupational Health

Cannabidiol use and perceptions in France: a national survey

Clemence Casanova, Clemence Ramier, Davide Fortin, Patrizia Carrieri, Julien Mancini, Tangui Barre

Summary: This French study found that 10% of adults used CBD, and several user profiles emerged based on demographic and behavioral characteristics. The results suggest the need for clearer European CBD regulations to ensure safe and high-quality products.

BMC PUBLIC HEALTH (2022)

Letter Substance Abuse

Exploring the medical cannabis prescribing behaviours of French general practitioners

Tangui Barre, Helene Venturino, Vincent Di Beo, Patrizia Carrieri, Anne-Laure Pelissier-Alicot

DRUG AND ALCOHOL REVIEW (2023)

Article Water Resources

Assessment of the Long-Term Exposure to Lead in Four European Countries Using PBPK Modeling

Moustapha Sy, Dimitra Eleftheriadou, Christian Jung, Oliver Lindtner, Spyros Karakitsios, Dimosthenis Sarigiannis, Till Weber, Marike Kolossa-Gehring, Matthias Greiner

Summary: This study aimed to develop an integrative modeling framework to assess the long-term exposure to lead in Belgium, Czech Republic, Germany, and Norway. The framework used estimates of external exposure to predict the concentrations of lead in human blood (PbB) and accounted for past and current exposure events. The modeling approach included a population-based simulation using a two-dimensional Monte Carlo approach to characterize the inter-individual variability and uncertainty in external exposure estimates. The predicted PbB levels were compared with HBM data.

EXPOSURE AND HEALTH (2023)

Article Substance Abuse

A novel community-based therapeutic education program for reducing alcohol-related harms and stigma in people with alcohol use disorders: A quasi-experimental study (ETHER study)

Tangui Barre, Clemence Ramier, Saskia Antwerpes, Marie Costa, Morgane Bureau, Gwenaelle Maradan, Vincent Di Beo, Christophe Cutarella, Jacques Leloutre, Olivier Riccobono-Soulier, Sophie Hedoire, Elodie Frot, Fabienne Vernier, Stephanie Vassas-Goyard, Sabine Dufort, Camelia Protopopescu, Fabienne Marcellin, Danielle Casanova, Marion Coste, Patrizia Carrieri

Summary: Alcohol use disorder (AUD) is a significant problem in France, but barriers such as stigma and apprehension about total abstinence contribute to a large treatment gap. This study assesses the effectiveness of the Choizitaconso TPE program for people with AUD, finding improvements in internalized stigma.

DRUG AND ALCOHOL REVIEW (2023)

Editorial Material Neurosciences

French general practitioners and medical cannabis: A need for training

Tangui Barre, Helene Venturino, Vincent Di Beo, Patrizia Carrieri, Anne-Laure Pelissier-Alicot

ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2023)

Article Nursing

Symptom severity is a major determinant of cannabis-based products use among people with multiple sclerosis

Tangui Barre, Damien Testa, Melina Santos, Fabienne Marcellin, Perrine Roux, Patrizia Carrieri, Lise Radoszycki, Camelia Protopopescu

Summary: This study aimed to identify factors associated with cannabinoid-based product (CBP) use in multiple sclerosis (MS) patients in France and Spain. The results showed that the prevalence of CBP use was similar in both countries, and the severity of MS was associated with CBP use.

JOURNAL OF CLINICAL NURSING (2023)

Article Psychology, Clinical

Exclusive Therapeutic Use of Cannabis in a Large Sample of Daily Cannabis Users in France: A Cross-Sectional Survey

Martin Bastien, Salim Mezaache, Cecile Donadille, Victor Martin, Laurent Appel, Maela Lebrun, Laelia Briand Madrid, Tangui Barre, Perrine Roux

Summary: Many cannabis users in France reported therapeutic benefits from cannabis consumption even without medical recommendation. A cross-sectional survey was conducted in 2020, collecting data from 4150 daily cannabis users. Approximately 10% of the participants exclusively used cannabis for therapeutic purposes. Exclusive therapeutic users differed from non-exclusive users in terms of age, employment, urban residence, physical and mental health condition, mode of cannabis administration, frequency of use, home cultivation, at-risk alcohol use, and previous-month opiate use. Understanding the profiles of regular cannabis users can inform harm reduction strategies and improve access to care for this population. Further research is needed to clarify the boundaries between therapeutic and recreational use.

JOURNAL OF PSYCHOACTIVE DRUGS (2023)

Article Substance Abuse

Screening for alcohol use in primary care: assessing French general practitioner practices

Tangui Barre, Vincent Di Beo, Perrine Roux, Abbas Mourad, Pierre Verger, Lisa Fressard, Thomas Herault, Jean-Francois Buyck, Francois Beck, Patrizia Carrieri

Summary: Alcohol use is a significant risk factor for premature death and disability. To address this issue, it is important for healthcare systems, particularly general practitioners (GPs), to conduct more frequent and accurate screening for at-risk consumption. This study examined the screening practices of GPs in France and identified factors associated with more frequent screening and the use of validated screening tools. The results showed an improvement in screening practices, but training and perceptions still hinder systematic and accurate screening.

ALCOHOL AND ALCOHOLISM (2023)

Letter Gastroenterology & Hepatology

Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH)

Tangui Barre, David Zucman, Fabienne Marcellin, Clemence Ramier, Camelia Protopopescu, Raphaelle Tardieu, Karine Ory, Dominique Salmon-Ceron, Patrizia Carrieri

JOURNAL OF VIRAL HEPATITIS (2023)

Letter Clinical Neurology

Cannabis-based products and multiple sclerosis-related pain: The role of routes of administration

Tangui Barre, Damien Testa, Clemence Ramier, Melina Santos, Fabienne Marcellin, Perrine Roux, Patrizia Carrieri, Lise Radoszycki, Camelia Protopopescu

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2023)

Article Gastroenterology & Hepatology

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

Fabienne Marcellin, Sylvie Bregigeon-Ronot, Clemence Ramier, Camelia Protopopescu, Camille Gilbert, Vincent Di Beo, Claudine Duvivier, Morgane Bureau-Stoltmann, Eric Rosenthal, Linda Wittkop, Dominique Salmon-Ceron, Patrizia Carrieri, Philippe Sogni, Tangui Barre

Summary: This study aimed to investigate the prevalence of moderate-to-severe depression in people living with HIV and HCV after successful HCV treatment, and identify associated socio-behavioral factors. Through descriptive and logistic regression analyses of data from 398 participants, it was found that 23.9% of HCV-cured individuals had moderate-to-severe depression. Female sex, unhealthy alcohol use, sedentary lifestyle, and unhealthy eating behaviors were associated with increased odds of moderate-to-severe depression.

JHEP REPORTS (2023)

Article Psychology, Clinical

Therapeutic Use and Other Reasons to Consume Cannabidiol: Insight from the French and Italian Contexts

Davide Fortin, Vincent Di Beo, Patrizia Carrieri, Tangui Barre

Summary: This study explored the characteristics of French and Italian CBD users based on their primary reason for use. Users' characteristics differed based on their reasons to use CBD, but there were similarities between both countries for users who used CBD for therapeutic purposes. Analyzing the reasons for CBD use can help to characterize users and identify their unmet needs in terms of self-care.

JOURNAL OF PSYCHOACTIVE DRUGS (2023)

Article Pharmacology & Pharmacy

Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock?

Tangui Barre, Vincenzo Di Marzo, Fabienne Marcellin, Patrizia Burra, Patrizia Carrieri

Summary: Obesity and nonalcoholic fatty liver disease (NAFLD) are global epidemics. The endocannabinoid system is seen as a key target for treating NAFLD. Although clinical trials are lacking, research suggests potential benefits of phytocannabinoids in treating liver steatosis. Cannabis plant should be considered a major prospect for NAFLD treatment. Overcoming scientific and non-scientific barriers is necessary for further research.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

Tangui Barre, Fabrice Carrat, Clemence Ramier, Helene Fontaine, Vincent Di Beo, Morgane Bureau, Celine Dorival, Dominique Larrey, Elisabeth Delarocque-Astagneau, Philippe Mathurin, Fabienne Marcellin, Ventzislava Petrov-Sanchez, Carole Cagnot, Patrizia Carrieri, Stanislas Pol, Camelia Protopopescu

Summary: The use of cannabis is associated with smaller waist circumference, lower BMI, and lower risks of overweight, obesity, and central obesity in patients with chronic HCV infection. Longitudinal studies are needed to confirm these relationships and assess the impact of cannabis use on body weight and liver outcomes after HCV cure.

JOURNAL OF CANNABIS RESEARCH (2022)

No Data Available